Lindbrook Capital, LLC Nevro Corp Transaction History

Lindbrook Capital, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$7.96 - $13.59 $5,030 - $8,588	632 Added 2430.77%	658 $5,000
Q1 2024 Apr 25, 2024	SELL	$13.56 - $20.78 $596 - $914	-44 Reduced 62.86%	26 $0
Q4 2023 Jan 31, 2024	SELL	$14.18 - $22.31 $2,127 - $3,346	-150 Reduced 68.18%	70 $1,000
Q3 2023 Oct 25, 2023	BUY	$18.22 - $25.85 $4,008 - $5,687	220 New	220 $4,000
Q1 2023 Apr 26, 2023	BUY	$30.17 - $41.11 $7,089 - $9,660	235 Added 1566.67%	250 $9,000
Q4 2022 Jan 24, 2023	SELL	$36.43 - $49.4 $10,163 - $13,782	-279 Reduced 94.9%	15 $0
Q3 2022 Nov 10, 2022	BUY	$40.66 - $53.03 $10,165 - $13,257	250 Added 568.18%	294 $14,000
Q2 2022 Aug 01, 2022	BUY	$40.85 - $77.67 $367 - $699	9 Added 25.71%	44 $2,000
Q1 2022 Apr 21, 2022	SELL	$59.95 - $92.06 $1,678 - $2,577	-28 Reduced 44.44%	35 $3,000
Q4 2021 Jan 18, 2022	BUY	$81.07 - $121.29 $4,458 - $6,670	55 Added 687.5%	63 $5,000
Q3 2021 Nov 05, 2021	SELL	$101.99 - $166.36 $305 - $499	-3 Reduced 27.27%	8 $1,000
Q1 2021 Apr 28, 2021	BUY	$132.81 - $182.18 $1,460 - $2,003	11 New	11 $2,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.